Data Fig. 3c and d) . Furthermore, some ERVs carried marks of active promoters or enhancers (Extended Data Fig. 3d and e). We also observed LTR12C subfamily had substantial H3K27ac enrichment across different tissues (Extended Data Fig. 3e and f) . Interestingly, the individual members appeared tissue restricted, suggesting that although the subfamily can be classified as non-tissue restrictively active, individual LTR12C elements were active only in distinct tissue/cell-types (Extended Data Fig. 3e ). Taken together, the data illustrates that human ERVs display precisely controlled patterns of activity in distinct tissues.
Intriguingly, 15 .2% (n=3,717) of strong promoters were also predicted as enhancers in other tissues, analogous to observations in mice, where intragenic enhancers act as promoters to produce cell-type specific transcripts 19 . These sites possessed histone modification signatures of active enhancers in some tissue/cell-types but were enriched with active promoter marks in others. We termed these sequences cis-Regulatory Elements with Dynamic Signatures (cREDS). For example, cREDS enhancers showed enrichment of H3K27ac and H3K4me1 and a striking depletion of H3K4me3 in lung ( Fig. 1b and c, Supplementary table 3). However, the signature shifted to that of active promoters in other tissues ( Fig. 1b and c) . cREDS are also found in other cell/tissue-types (Extended Data Fig.  4a ). To determine whether cREDS are dual functional, we selected a subset of promotermarked elements and validated their function with a luciferase reporter assay in hESCs. The majority (7 of 10) indeed showed promoter activity (Extended Data Fig. 4b ). Similarly, 10 of 11 selected cREDS with enhancer signatures in hESCs also functioned as enhancers (Extended Data Fig. 4c ). Additionally, subsets of enhancers previously validated in transgenic mice also possessed dynamic signatures (Extended Data Fig. 5 ) 20 . Furthermore, we selected two cREDS, predicted as enhancers in the left heart ventricle, with significant CAGE signal 21 , typical of active promoters (Extended Data Fig. 6a-b ) and found that they possess heart-restricted enhancer activities in an in vivo zebrafish reporter assay (Extended Data Fig. 6c ). Consistent with reporter activities, transcriptional properties (RNA-seq values ±1kb of the elements) of cREDS enhancers and promoters are similar to non-cREDS enhancers and promoters, respectively (Fig. 1d) . Interestingly, when comparing isoform dynamics across H1 and IMR-90 RNA-seq datasets 22 , with cREDS identified between these two cell-types, we discovered a subset of cREDS promoters were accompanied by creation of new transcripts and/or alternative exon usage (n=99) (Fig. 1e) , revealing a possible function, whereby cREDS influence cell/tissue-specific transcript variants. Taken together, these data show that cREDS can potentially function as both promoters and enhancers in distinct cell-types and fine-tune transcriptomes.
Reasoning that global analysis of allelic histone modification and gene expression patterns would elucidate mechanisms of long-range gene regulation by distal cis-regulatory elements, we re-analyzed RNA-seq and ChIP-seq datasets by considering haplotype information. For this purpose, we applied Haploseq 1 , which integrated genome sequencing with highthroughput chromatin conformation capture (Hi-C) datasets to derive chromosome-spanning haplotypes (see Supplementary Information). For four different tissue donors, we generated haplotypes spanning entire chromosomes with 99.5% completeness on average (the coverage of haplotype resolved genomic regions) and average resolution (the coverage of phased heterozygous SNPs) ranging from 78% to 89% (Fig. 2a and Supplementary table 4  and 5 ). The accuracy of haplotype predictions was validated by the concordance with SNPs residing in the same paired-end sequencing reads. The concordance rates were 99.7% and 98.4% for H3K27ac ChIP-seq reads (described below) and RNA-seq reads, respectively, indicating high accuracy. We then re-analyzed 36 mRNA-seq datasets from 18 tissues (including 16 tissues noted above with the addition of bladder and adipose tissue) and 187 ChIP-seq datasets for 6 histone modifications (Supplementary Table 6 ), from up to 4 individual donors, in a haplotype-resolved context.
Although widespread allelic imbalances in gene expression had been previously noted 7, [23] [24] [25] , it remains unclear whether this phenomenon is consistent across distinct tissues and individuals and the underlying mechanism. To address the prior, we defined genes with allelically biased expression mapping the RNA-seq reads in each tissue sample to the two haploid genomes of the donor. We observed extensive allelically biased gene expression, ranging from 4% to 13% of all informative genes (>10 allelic read counts) in each tissue sample (FDR=5%, Extended Data Fig. 7a-b) . Comparatively, the proportion of allelically biased genes in individual tissue donors ranged from 6% to 23% of all informative genes, giving a combined total of 2,570 allelically biased genes (Fig. 2b , Supplementary Table 7) . As a control, known imprinted genes (n=17) showed common allelic biases across multiple samples ( Fig. 2c ) and donors (Extended Data Fig. 7c ). Our datasets, representing the only collection of haplotype-resolved transcriptomes across an array of tissues from multiple individuals, allowed us to characterize allelic transcription across tissues and donors. While most genes with allelically biased expression demonstrate bias in multiple samples, approximately 75% exhibit statistically significant donor-specific bias (Fig. 2d , and Extended Data Fig. 7d ). This suggests a connection between sequence differences of individuals and allelically biased gene expression. In support of this model, genes frequently demonstrate consistent direction of allelic bias across multiple tissues of a given donor ( Fig.  2e and Extended Data Fig. 7e ). Interestingly, allelically biased genes were not restricted to the same tissue-type across distinct donors. Rather, they were mostly specific to individual samples derived from each donor ( Fig. 2f and Extended Data Fig. 7f ), possibly resulting from differential levels of tissue-restricted TFs amongst different tissue samples.
As natural genetic variations can affect enhancer selection and function in mammalian cells 26 , we hypothesized that polymorphisms at cis-regulatory sequences underlie the widespread allelic transcriptional biases. We thus exploited the unique resource of 187 haplotype-resolved ChIP-seq datasets to analyze the state of cis-regulatory elements. We identified allelically biased marks at promoter regions (H3K27ac, H3K4me1, H3K4me3, H3K27me3 and H3K9me3) and transcribed gene bodies (H3K36me3) (see Supplementary Information). In support of our hypothesis, the allelic biases of gene expression strongly agreed with chromatin states of sequences at or near the genes (Fig. 3a,b , and Extended Data Fig. 8a ).
Furthermore, if allelic imbalances of enhancer activities indeed contributed to allelically biased gene expression, we expected that chromatin states at enhancers would be concordant with the expression of their targets. Therefore, we generated additional H3K27ac ChIP-seq datasets with deeper coverage and longer sequencing reads (for better delineation of alleles) for 14 of the previously analyzed tissue samples and an additional 6 samples from independent donors (Supplementary Table 7 ). Of the informative enhancers (with >10 polymorphism-bearing sequence reads), 11.6% (n=11,714, FDR=1%) showed significant allelically biased H3K27ac enrichment in any tissue types (Fig. 3c , and Supplementary table 8). H3K27ac biases were validated by allele-specific ChIP-qPCR (Extended Data Fig. 8b ). Interestingly, identical genotypes often yielded the same direction of biases in allelic enhancer activities (Fig. 3d) . We further tested whether sequence variations are systematically associated with allelic H3K27ac, which reflects enhancer activities 27 . Indeed, H3K27ac biases were strongly correlated with specific genotypes, whereby given identical genotypes, this histone modification was biased to the same alleles, both across tissue-types and individuals (Fig. 3d-f and Extended Data Fig. 9a ). Furthering this finding, we analyzed previously generated datasets from lymphoblastoid cell-lines 28 and found similar significant correlation of genotype and molecular phenotype of H3K27ac enrichment (Extended Data Fig. 9b ). Taken together, these data reveal that extensive allelic imbalance events are associated with sequence variants in cis-regulatory elements.
Intriguingly, we discovered allelic enhancers resided in significantly closer proximity to genes with allelically biased expression, as compared to non-allelic enhancers ( Fig. 4a and  4b ). We also observed examples where distinct tissues from the same donor showed similar allelic biases of gene expression and H3K27ac at enhancers (left ventricle and right ventricle from donor3); however, the same tissue-type derived from a different donor (left ventricle from donor1) yielded no consistent patterns (Fig. 4b) , supporting the hypothesis that allelically biased gene expression is driven by individual-specific genetic variation in enhancers. Indeed, within close proximity, the concordance between allelic enhancers and gene expression is significantly higher than permutated control enhancer/gene sets (Fig. 4c) . Remarkably, 56% of allelic enhancer-gene pairs are greater than 300kb apart (Extended Data Fig. 10a and b) , the delineation of which was enabled by whole chromosome-spanning haplotypes.
Similar to genes, many allelically biased enhancers are tissue-restricted (Extended Data Fig.  10c ). We reasoned that gene expression biases could result from tissue-restricted enhancer activities, supported by significant correlation between allelic enhancers and allelically expressed genes (Fig. 4d) . Allelic enhancers also significantly overlapped with expression quantitative trait loci (eQTLs) (Fig 4e) , DNaseI hypersensitivity QTLs and H3K27ac QTLs (Extended Data Fig. 10d ), defined independently [28] [29] [30] , corroborating the functional roles of identified allelic enhancers on gene regulation. Taken together, these observations support a model whereby allelic biases of cis-regulatory element activities could be responsible for allelic gene expression.
Finally, to further elucidate the mechanism by which allelically biased enhancer activities arise, we examined SNPs that potentially disrupt or weaken TF binding motifs. We calculated changes in motif score between alleles (motif disruption score) at allelic enhancers and discovered 133 TF motifs showing significant concordance between allelic reduction of enhancer activities and TF motif disruption ( Fig. 5a and b) (FDR=10%, Supplementary Table 9 )(see Supplementary Information). Moreover, genes with allelically biased expression were concordant with enhancer motif disruptions within close proximity (<20kb) or displaying strong Hi-C interactions at longer distances (>20kb)(see Supplementary Information) (Fig. 5c) . Our results therefore suggest that genetic variations are likely responsible for allelic enhancer activities and consequently allelically biased gene expression.
In summary, by generating chromosome-spanning haplotypes, we carried out a comprehensive survey of allelic chromatin state and gene expression. We found evidence for extensive allelically biased gene expression, which is connected to change in chromatin states at cis-regulatory elements, likely resulting from TF binding disruption by sequence variations. These observations echo findings in mice where allelic biases of cis-regulatory element activities could be responsible for allelic gene expression 26 and demonstrate that such phenomenon is likely widespread in the human genome, too. These observations shed light on the importance of considering genetic variants in understanding individual-specific gene regulation. Analyses of haplotype-resolved transcriptomes and epigenomes in additional individuals and tissues should further illuminate the role of sequence variations in defining individual-specific transcriptional programs and phenotypes.
Extended Data
Extended data Figure 1 . Active enhancers cluster along developmental lineages a) Pie charts showing fractions of tissue-restricted and non-tissue-restricted strong enhancers and promoters. b) Hierarchical clustering with optimal leaf ordering based on all H3K27ac marked highly active enhancers. Four major clusters are represented: early embryonic celltypes (blue), a large set of meso/endoderm-derived tissues (dark green), a set consisting of ectoderm-derived brain tissues (red) and a small cluster of mesoderm cell lines (purple), which bridged the early embryonic lineages with the somatic tissues. It is worth noting that although TRO did not fall within any clusters, it shared the highest degree of similarity with the early embryonic cell lines. On a subsequent level, two clusters are seen separating endoderm-derived tissues (gray line) and mesoderm-derived tissues (green line). Heart tissues are denoted by yellow asterisk. c) Clustering of tissues by promoters histone acetylation status shows grouping of tissues that are of similar types but are less evident in germ-layer divisions than clustering of enhancers. . Three tissue samples were randomly selected and, sample-restricted allelically expressed genes were defined, which includes random variance effect. The random selection was repeated 10,000 times. Shaded blue box indicates the range of fractions of individual-restricted allele biased genes in all analyzed tissues-types (n=10). The fraction of sample-restricted allelically biased genes is lower than individual-restricted allele biased genes in Figure 2e . e) Fold change of allele biased gene expression between two alleles are shown as scatter plot. X-axis is for the fold changes in one randomly selected tissue in each donor and y-axis is for the fold changes in all other remaining tissues in the corresponding donor. Allelic bias in one tissue is highly correlated with allelic bias in other tissues in the same individual. f) A histogram illustrates the proportions of allelically expressed genes in donor 2 (left) and 3 (right) defined in various numbers of tissues. The fraction of all testable genes or allelically expressed genes (y-axis) is calculated for the number of tissues where they are called as active (x-axis). The results indicate that the majority of allelically biased genes, as oppose to testable genes, are restricted to 1 or 2 tissue samples. KS-test was performed between allele biased genes and testable genes (p-value < 2.2e-16).
Extended data Figure 8 . Allele biased chromatin states a) Boxplots illustrating haplotype-resolved ChIP-seq signal enrichment on the two alleles at promoter regions. The P1 or P2 allele biased promoter regions were defined by H3K27ac signals and then H3K4m1, H3K4me3, and H3K9me3 signals were presented for the corresponding promoter regions. All chromatin states are consistent according to the allele biased H3K27ac patterns. KS-test was performed for p value calculation. b) Allelically biased enhancers were tested in thymus from donor 1, pancreas from donor 2 and 3. H3K27ac enrichment was tested by allele-specific ChIP-qPCR. Two control enhancers were included and showed to have no allelic biases in thymus or pancreas from donor 2 (top right and bottom left, respectively). 
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. 
